References
- Martin JLR, Sainz-Pardo M, Furukawa TA et al. Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. J. Psychopharmacol.21, 774–782 (2007).
- Kessler RC, DuPont RL, Berglund HU et al. Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. Am. J. Psychiatry156, 1915–1923 (1999).
- Nutt D, Argyropoulos S, Hood S et al. Generalized anxiety disorder; a comorbid disease. Eur. Neuropsychopharmacol.16(Suppl. 2), 109–118 (2006).
- Wittchen HU, Zhao S, Kessler RC et al. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry51, 355–364 (1994).
- Schweizer E, Rickels K. Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta Psychiatrica. Scand. Suppl.393, 95–101 (1998).
- Rynn MA Brawman-Mintzer O. Generalized anxiety disorder: acute and chronic treatment. CNS Spectr.9, 716–723 (2004).
- Struzik L, Vermani M, Coonerty-Femiano A et al. Treatments for generalized anxiety disorder. Expert Rev. Neurother.4, 285–294 (2004).
- Mitte K, Noack P, Steil R et al. A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder. J. Clin. Psychopharmacology25, 141–150 (2005).
- Everitt BS, Wessely S. Clinical Trials in Psychiatry (Second Edition), John Wiley & Sons, Chichester, UK (2008).
- Hofmann SG, Smits JAJ. Cognitive–behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J. Clin. Psychiatry69, 621–432 (2008).
- National Institute for Clinical Excellence (NICE). Clinical Guidelines for the Management of Anxiety (Panic Disorder, With or Without Agoraphobia and Generalised Anxiety) in Adults in Primary, Secondary and Community Care. NICE, London, UK (2004).
- Barker MJ, Greenwood KM, Jackson M et al. Cognitive effects of long-term benzodiazepine use. CNS Drugs18, 37–48 (2004).
- Vasile RG, Bruce SE, Goisman RM et al. Results of a naturalistic longitudinal study of benzodiazepine and SSRI use in the treatment of generalized anxiety disorder and social phobia. Depression Anxiety22, 59–67 (2005).
- Stahl SM. Don’t ask, don’t tell, but benzodiazepines are still the leading treatments for anxiety disorder. J. Clin. Psychiatry63, 756–757 (2002).